Abbott Labs to buy diagnostics company Alere for $5.8 billion

Go back to Abbott Labs to buy diagnostics company Alere for $5.8 billion

Jefferies Downgrades Alere (ALR) to Hold Following Takeover

February 2, 2016 7:58 AM EST

Jefferies downgraded Alere (NYSE: ALR) from Buy to Hold with a price target of $56.00 (from $54.00) after the company agreed to be acquired by Abbott Laboratories.

For an analyst ratings summary and ratings history on Alere... More